Cargando…
Dibenzazecine compounds with a novel dopamine/5HT(2A )receptor profile and 3D-QSAR analysis
BACKGROUND: Antipsychotics are divided into typical and atypical compounds based on clinical efficacy and side effects. The purpose of this study was to characterize in vitro a series of novel azecine-type compounds at human dopamine D(1)-D(5 )and 5HT(2A )receptors and to assign them to different cl...
Autores principales: | Hamacher, Alexandra, Weigt, Mathias, Wiese, Michael, Hoefgen, Barbara, Lehmann, Jochen, Kassack, Matthias U |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1586004/ https://www.ncbi.nlm.nih.gov/pubmed/16978403 http://dx.doi.org/10.1186/1471-2210-6-11 |
Ejemplares similares
-
Ellagic Acid and Resveratrol Prevent the Development of Cisplatin Resistance in the Epithelial Ovarian Cancer Cell Line A2780
por: Engelke, Laura H., et al.
Publicado: (2016) -
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
por: Gohr, Katharina, et al.
Publicado: (2017) -
QSAR workbench: automating QSAR modeling to drive compound design
por: Cox, Richard, et al.
Publicado: (2013) -
Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines
por: Bandolik, Jan J., et al.
Publicado: (2019) -
A QSAR model of Olanzapine derivatives as potential inhibitors for 5-HT2A Receptor
por: Mitra, Pooja, et al.
Publicado: (2017)